These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32739889)
1. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction. Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889 [TBL] [Abstract][Full Text] [Related]
2. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL Manevski N; Umehara K; Parrott N Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687 [TBL] [Abstract][Full Text] [Related]
3. In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes. Docci L; Klammers F; Ekiciler A; Molitor B; Umehara K; Walter I; Krähenbühl S; Parrott N; Fowler S AAPS J; 2020 Oct; 22(6):131. PubMed ID: 33051808 [TBL] [Abstract][Full Text] [Related]
4. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes. Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366 [TBL] [Abstract][Full Text] [Related]
5. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Varma MV; Steyn SJ; Allerton C; El-Kattan AF Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985 [TBL] [Abstract][Full Text] [Related]
6. Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research. Li N; Badrinarayanan A; Ishida K; Li X; Roberts J; Wang S; Hayashi M; Gupta A AAPS J; 2020 Nov; 23(1):1. PubMed ID: 33196949 [TBL] [Abstract][Full Text] [Related]
7. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding. Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches. Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896 [TBL] [Abstract][Full Text] [Related]
9. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes. Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732 [TBL] [Abstract][Full Text] [Related]
10. Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs. Kimoto E; Mathialagan S; Tylaska L; Niosi M; Lin J; Carlo AA; Tess DA; Varma MVS J Pharmacol Exp Ther; 2018 Nov; 367(2):322-334. PubMed ID: 30135178 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance. Williamson B; Harlfinger S; McGinnity DF Drug Metab Dispos; 2020 Nov; 48(11):1137-1146. PubMed ID: 32847864 [TBL] [Abstract][Full Text] [Related]
12. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species. Tess DA; Ryu S; Di L Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289 [TBL] [Abstract][Full Text] [Related]
13. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake. Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410 [TBL] [Abstract][Full Text] [Related]
14. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Kosugi Y; Hosea N Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525 [TBL] [Abstract][Full Text] [Related]
15. Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules. Trunzer M; Teigão J; Huth F; Poller B; Desrayaud S; Rodríguez-Pérez R; Faller B Drug Metab Dispos; 2024 Apr; 52(5):345-354. PubMed ID: 38360916 [TBL] [Abstract][Full Text] [Related]
16. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Chan TS; Yu H; Moore A; Khetani SR; Tweedie D Drug Metab Dispos; 2013 Dec; 41(12):2024-32. PubMed ID: 23959596 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling. Kratochwil NA; Meille C; Fowler S; Klammers F; Ekiciler A; Molitor B; Simon S; Walter I; McGinnis C; Walther J; Leonard B; Triyatni M; Javanbakht H; Funk C; Schuler F; Lavé T; Parrott NJ AAPS J; 2017 Mar; 19(2):534-550. PubMed ID: 28050713 [TBL] [Abstract][Full Text] [Related]
18. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation. Francis LJ; Houston JB; Hallifax D Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201 [TBL] [Abstract][Full Text] [Related]
19. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System. El-Kattan AF; Varma MV; Steyn SJ; Scott DO; Maurer TS; Bergman A Pharm Res; 2016 Dec; 33(12):3021-3030. PubMed ID: 27620173 [TBL] [Abstract][Full Text] [Related]
20. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds. Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]